Chris Whitehouse, a political consultant and expert on medical technology policy and regulation at Whitehouse Communications, welcomes new leadership at the top of the UK’s MedTech regulator. The National Institute for Health and Care Excellence (NICE) has announced Professor Jonathan Benger CBE as
Chris Whitehouse, a political consultant and expert on medical technology policy and regulation at Whitehouse Communications, encourages MedTech trade bodies to engage in shaping new government guidance on declaration of payments. New guidelines will be published by Government to require MedTech sup
Two pioneering, clinically-led digital app solutions have won the Ripple Women’s Digital Health Challenge – a global innovation programme, delivered by Cogniss in partnership with the Health Innovation Network (the Network) and Amazon Web Services (AWS). The two winning app ideas, developed by clini
Chris Whitehouse, a political consultant and expert on medical technology policy and regulation at Whitehouse Communications, highlights the importance of a call for evidence on AI regulation in MedTech. The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has launched a pivotal “Call
As the NHS 10 Year Health Plan moves from ambition to implementation, 2026 is shaping up to be a pivotal year for MedTech and digital health. Med-Tech Insights reached out to leaders from across the industry to ask them to share their expectations for the year ahead. From value-based procurement to
Chris Whitehouse, a political consultant and expert on medical technology policy and regulation at Whitehouse Communications, and advisor to MedTech suppliers reports on a new collaboration to use nuclear waste in cancer-fighting MedTech. In a landmark move set to redefine cancer treatment, Bicycle
Chris Whitehouse, a political consultant and expert on medical technology policy and regulation at Whitehouse Communications, and advisor to MedTech suppliers highlights a new UK/Singapore joint venture to encourage innovation in MedTech. The UK and Singapore have launched a groundbreaking “regulato
Flow Neuroscience has announced FDA approval of its breakthrough Flow at-home brain-stimulation device for the treatment of major depressive disorder (MDD). The company says the FDA approval marks the first time in history American clinicians are able to prescribe a novel at-home non-drug therapy as
Boston Scientific has announced that Health Care Service Corporation (HCSC), one of the largest commercial health insurers in the U.S., now covers the Intracept Procedure for eligible patients with chronic vertebrogenic low back pain. The policy went into effect December 1, 2025 and covers more than
Chris Whitehouse, a political consultant and expert on medical technology policy and regulation at Whitehouse Communications, and advisor to MedTech suppliers assesses the positive implications for MedTech of a controversial decision to allow government to dictate the level of value thresholds adopt
Bethan Halliwell, Partner, and Lucy Tedstone, Associate, of European IP firm Withers & Rogers highlight the challenges of sustainable innovation, and explain how building an IP strategy with sustainability at its core can turn environmental responsibility into competitive advantage. Sustainability i
Bendit Technologies is proud to announce that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the Bendit17 Microcatheter, the smallest steerable microcatheter on the market. This milestone marks a significant step forward in advancing precision and accessibility in neuro
